“It's metastases that kills most cancer patients. And today, when we treat cancer, we often base our approach on what we know about the primary tumor, while metastases remain an underexplored area in many ways”, says Catharina Hagerling, associate professor and research group leader at Lund University.
She is one of the speakers at Life Science Sw...
Cancer researcher: “We can do better and reduce suffering”
Lund University researcher Catharina Hagerling is developing innovative methods to understand metastatic cancer, aiming to create more targeted treatments for patients with disseminated cancer.
Catharina Hagerling conducts research on metastatic neuroblastoma, a particularly aggressive form of neuroblastoma with a survival rate of less than 50 percent. Photo: Johan Bävman
Vill du få åtkomst till allt?
Prova 30 dagar för 0 kr.
Inga bindningstider eller kortuppgifter krävs.
Prova nu
Köp en prenumeration
Utforska våra prenumerationslösningar och välj den som passar dina behov.
Välj din prenumeration